.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
US Army
Citi
US Department of Justice
UBS
Merck
Argus Health
Fuji
Queensland Health

Generated: November 19, 2017

DrugPatentWatch Database Preview

Cerivastatin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for cerivastatin sodium and what is the scope of cerivastatin sodium patent protection?

Cerivastatin sodium
is the generic ingredient in one branded drug marketed by Bayer Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for cerivastatin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-004Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-002Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-006Jul 24, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-003Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-001Jun 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-005May 24, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cerivastatin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-004Jun 26, 1997► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-001Jun 26, 1997► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-002Jun 26, 1997► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-005May 24, 1999► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-006Jul 24, 2000► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-003Jun 26, 1997► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-002Jun 26, 1997► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-004Jun 26, 1997► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-001Jun 26, 1997► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-003Jun 26, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Express Scripts
Mallinckrodt
Federal Trade Commission
Chubb
Daiichi Sankyo
Boehringer Ingelheim
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot